An investor’s guide to Canada’s publicly traded pot companies
Throughout this week, we’re telling you everything you need to know to navigate the semi-legal new world of weed. Here, a guide to some of the legit medical cannabis corporations currently vying for investor dollars
The Juggernaut: Canopy Growth (CGC)
Year founded: 2014 Notable principal: Mark Zekulin, president of subsidiary Tweed, was senior advisor to Ontario finance minister Dwight Duncan Growing area: 573,000 square feet Annual capacity: 5,740 kilograms Revenue in last quarter: $2.5 million Share price: $2.68 Market cap: $272 million Listed on: TSX Venture
The Upstart: Aphria (APH)
Year founded: 2013 Notable principal: President and CEO Vic Neufeld was CEO of the Jamieson vitamin company Growing area: 22,000 square feet Annual capacity: 2,000 kilograms Revenue in last quarter: $2 million Share price: $1.19 Market cap: $63.5 million Listed on: TSX Venture
The Maritimer: OrganiGram Holdings (OGI)
Year founded: 2013 Notable principal: President Roger Rogers was VP of Moosehead Breweries Growing area: 31,000 square feet Annual capacity: 600 kilograms Revenue in last quarter: $675,500 Share price: $0.79 Market cap: $44.5 million Listed on: TSX Venture
The Pioneer: Mettrum Health (MT)
Year founded: 2012 Notable principal: CEO Michael Haines was chairman of Blammo Games Growing area: 87,000 square feet Annual capacity: 3,500 kilograms Revenue in last quarter: $1.7 million Share price: $1.75 Market cap: $59 million Listed on: TSX Venture
The Newbie: Aurora Cannabis (ACB)
Year founded: 2013 Notable principal: Director Chuck Rifici is CFO of the federal Liberal party Growing area: 55,200 square feet Annual capacity: 5,400 kilograms Revenue in last quarter: N/A Share price: $0.54 Market cap: $73.8 million Listed on: Canadian Securities Exchange
